Antagonism of peripheral inflammation reduces the severity of status epilepticus

Neurobiology of Disease

Volumn 33, Issue 2, 2009, Pages 171-181

  Marchi, Nicola ^a   Fan, Qingyuan ^a   Ghosh, Chaitali ^a   Fazio, Vincent ^a   Bertolini, Francesca ^a   Betto, Giulia ^a   Batra, Ayush ^a   Carlton, Erin ^a   Najm, Imad ^a   Granata, Tiziana ^b   Janigro, Damir ^a  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Anti inflammatory therapy; Blood brain barrier; Cerebrovascular function; Epilepsy; Inflammation; New drug targets; T lymphocytes

Indexed keywords

INTERLEUKIN 1BETA; LITHIUM; PILOCARPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; ELECTROPHYSIOLOGY; EPILEPTIC STATE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; T LYMPHOCYTE; THETA RHYTHM;

ACTION POTENTIALS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD-BRAIN BARRIER; BRAIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLIOSIS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; LEUKOCYTES; LITHIUM CHLORIDE; MALE; MICROELECTRODES; PILOCARPINE; RATS; RATS, SPRAGUE-DAWLEY; STATUS EPILEPTICUS; THETA RHYTHM;

EID: 58149510132     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.10.002     Document Type: Article

References (55)

1. Abbott N.J., Khan E.U., Rollinson C., Reichel A., Janigro D., Dombrowski S., and Dobbie M.B.D.J. Drug resistance in epilepsy: the role of the blood-brain barrier. In: Ling V. (Ed). Mechanisms of drug resistance in epilepsy: lessons from oncology (2001), John Wiley, Chichester, UK 38-47
2. Addy R.O., Foliart R.H., Saran A.S., and Schubert D.S. EEG observations during combined haloperidol-lithium treatment. Biol. Psychiatry 21 (1986) 170-176
3. Araki T., Otsubo H., Makino Y., Elliott I., Iida K., Ochi A., Weiss S.K., Chuang S.H., Rutka J.T., and Snead III O.C. Efficacy of dexamathasone on cerebral swelling and seizures during subdural grid EEG recording in children. Epilepsia 47 (2006) 176-180
4. Bawden H.N., and Racine R.J. Effects of bilateral kindling or bilateral sub-threshold stimulation of the amygdala or septum on muricide, ranacide, intraspecific aggression and passive avoidance in the rat. Physiol. Behav. 22 (1979) 115-123
5. Carmen J., Okafor K., and Ike E. The effects of lithium therapy on leukocytes: a 1-year follow-up study. J. Natl. Med. Assoc. 85 (1993) 301-303
6. Cavaglia M., Dombrowski S.M., Drazba J., Vasanji A., Bokesch P.M., and Janigro D. Regional variation in brain capillary density and vascular response to ischemia. Brain Res. 910 (2001) 81-93
7. Cavalheiro E.A., Naffah-Mazzacoratti M.G., Mello L.E., and Leite J.P. The pilocarpine model of seizure. In: Pitkanen A., Mosh'e S.L., and Schwartzkroin P.A. (Eds). Epilepsy (2006), Elsevier 443-446
8. Cucullo L., Couraud P.O., Weksler B., Romero I.A., Hossain M., Rapp E., and Janigro D. Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies. J. Cereb. Blood Flow Metab. 28 (2008) 312-328
9. Cucullo L., Hallene K., Dini G., Dal Toso R., and Janigro D. Glycerophosphoinositol and dexamethasone improve transendothelial electrical resistance in an in vitro study of the blood-brain barrier. Brain Res. 997 (2004) 147-151
10. Dombrowski S., Desai S., Marroni M., Cucullo L., Bingaman W., Mayberg M.R., Bengez L., and Janigro D. Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia 42 (2001) 1504-1507
11. Dube C., Vezzani A., Behrens M., Bartfai T., and Baram T.Z. Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann. Neurol. 57 (2005) 152-155
12. Eisenberg S.P., Brewer M.T., Verderber E., Heimdal P., Brandhuber B.J., and Thompson R.C. Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 5232-5236
13. Elkassabany N.M., Bhatia J., Deogaonkar A., Barnett G.H., Lotto M., Maurtua M., Ebrahim Z., Schubert A., Ference S., and Farag E. Perioperative complications of blood brain barrier disruption under general anesthesia: a retrospective review. J. Neurosurg. Anesthesiol. 20 (2008) 45-48
14. Fieschi C., Lenzi G.L., Zanette E., Orzi F., and Passero S. Effects on EEG of the osmotic opening of the blood-brain barrier in rats. Life Sci. 27 (1980) 239-243
15. Galic M.A., Riazi K., Heida J.G., Mouihate A., Fournier N.M., Spencer S.J., Kalynchuk L.E., Teskey G.C., and Pittman Q.J. Postnatal inflammation increases seizure susceptibility in adult rats. J. Neurosci. 28 (2008) 6904-6913
16. Gilbert M.E. Repeated exposure to lindane leads to behavioral sensitization and facilitates electrical kindling. Neurotoxicol. Teratol. 17 (1995) 131-141
17. Granata T. Rasmussen's syndrome. Neurol. Sci. 24 Suppl. 4 (2003) S239-S243
18. Grant G.A., and Janigro D. The blood-brain barrier. In: Winn H.R. (Ed). Youmans neurological surgery (2004), Saunders, Philadelphia (Pa) 153-174
19. Haspolat S., Baysal Y., Duman O., Coskun M., Tosun O., and Yegin O. Interleukin-1alpha, interleukin-1beta, and interleukin-1Ra polymorphisms in febrile seizures. J. Child Neurol. 20 (2005) 565-568
20. Helmchen H., and Kanowski S. EEG changes under lithium (Li) treatment. Electroencephalogr. Clin. Neurophysiol. 30 (1971) 269
21. Hesdorffer D.C. Risk factors. In: Engel J., and Pedley T.A. (Eds). Epilepsy: A Comprehensive Textbook (2008), Lippincott Williams & Wilkins, Philadelphia (Pa) 57-63
22. Hrachovy R.A., and Frost J.D. Adrenocorticotropin hormone and steroids. In: Engel G., and Pedley T.A. (Eds). Epilepsy: A Comprehensive Textbook (2008), Lippincott Williams and Wilkins, Philadelphia (Pa) 1519-1529
23. Ivens S., Kaufer D., Flores L.P., Bechmann I., Zumsteg D., Tomkins O., Seiffert E., Heinemann U., and Friedman A. TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 130 (2007) 535-547
24. Kaga S., Zhan L., Altaf E., and Maulik N. Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium. J. Mol. Cell. Cardiol. 40 (2006) 138-147
25. Kokate T.G., Cohen A.L., Karp E., and Rogawski M.A. Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice. Neuropharmacology 35 (1996) 1049-1056
26. Korn A., Golan H., Melamed I., Pascual-Marqui R., and Friedman A. Focal cortical dysfunction and blood-brain barrier disruption in patients with Postconcussion syndrome. J. Clin. Neurophysiol. 22 (2005) 1-9
27. Kroll R.A., and Neuwelt E.A. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 42 (1998) 1083-1099
28. Kuruvilla P.K., and Alexander J. Lithium toxicity presenting as non-convulsive status epilepticus (NCSE). Aust. N. Z. J. Psychiatry 35 (2001) 852
29. Marchi N., Angelov L., Masaryk T., Fazio V., Granata T., Hernandez N., Hallene K., Diglaw T., Franic L., Najm I., and Janigro D. Seizure-promoting effect of blood-brain barrier disruption. Epilepsia 48 4 (2007) 732-742
30. Marchi N., Oby E., Fernandez N., Uva L., de Curtis M., Batra A., Santaguida S., Barnes V., van Boxel A., Najm I., and Janigro D. In vivo and in vitro effects of pilocarpine: relevance to epileptogenesis. Epilepsia 48 10 (2007) 1934-1946
31. McIntyre D.C., and Racine R.J. Kindling mechanisms: current progress on an experimental epilepsy model. Prog. Neurobiol. 27 (1986) 1-12
32. Miyazaki M., Hashimoto T., Yoneda Y., Saijio T., Mori K., Ito M., and Kuroda Y. Adrenocorticotropic hormone therapy for infantile spasms alters pyruvate metabolism in the central nervous system. Brain Dev. 20 (1998) 312-318
33. Oby E., and Janigro D. The blood-brain barrier and epilepsy. Epilepsia 47 (2006) 1761-1774
34. Ostergaard L., Hochberg F.H., Rabinov J.D., Sorensen A.G., Lev M., Kim L., Weisskoff R.M., Gonzalez R.G., Gyldensted C., and Rosen B.R. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. J. Neurosurg. 90 (1999) 300-305
35. Roccatagliata L., Audenino D., Primavera A., and Cocito L. Nonconvulsive status epilepticus from accidental lithium ingestion. Am. J. Emerg. Med. 20 (2002) 570-572
36. Sayyah M., Javad-Pour M., and Ghazi-Khansari M. The bacterial endotoxin lipopolysaccharide enhances seizure susceptibility in mice: involvement of proinflammatory factors: nitric oxide and prostaglandins. Neuroscience 122 (2003) 1073-1080
37. Shaftel S.S., Carlson T.J., Olschowka J.A., Kyrkanides S., Matousek S.B., and O'Banion M.K. Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration. J. Neurosci. 27 (2007) 9301-9309
38. Shorvon S.D., Pellock J.M., and DeLorenzo R.J. Acute physiologic changes, morbidity, and mortality of status epilepticus. In: Engel G., and Pedley T.A. (Eds). Epilepsy: A Comprehensive Textbook (2008), Lippincott Williams and Wilkins, Philadelphia (Pa) 737-749
39. Skurk C., Maatz H., Rocnik E., Bialik A., Force T., and Walsh K. Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells. Circ. Res. 96 (2005) 308-318
40. Stolp H.B., Dziegielewska K.M., Ek C.J., Habgood M.D., Lane M.A., Potter A.M., and Saunders N.R. Breakdown of the blood-brain barrier to proteins in white matter of the developing brain following systemic inflammation. Cell Tissue Res. 320 (2005) 369-378
41. Stolp H.B., Dziegielewska K.M., Ek C.J., Potter A.M., and Saunders N.R. Long-term changes in blood-brain barrier permeability and white matter following prolonged systemic inflammation in early development in the rat. Eur. J. Neurosci. 22 (2005) 2805-2816
42. Suslov N.I., Fedorov A.A., Pershina O.V., Borodin Y.I., and Rachkovskaya L.N. Effect of Noolit, a novel lithium preparation, on electrophysiological activity of rat cerebral cortex. Bull. Exp. Biol. Med. 137 (2004) 155-158
43. Tomkins O., Friedman O., Ivens S., Reiffurth C., Major S., Dreier J.P., Heinemann U., and Friedman A. Blood-brain barrier disruption results in delayed functional and structural alterations in the rat neocortex. Neurobiol. Dis. 25 (2007) 367-377
44. Turski L., Ikonomidou C., Turski W.A., Bortolotto Z.A., and Cavalheiro E.A. Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse 3 (1989) 154-171
45. Ulrich G., Frick K., Stieglitz R.D., and Muller-Oerlinghausen B. Interindividual variability of lithium-induced EEG changes in healthy volunteers. Psychiatry Res. 20 (1987) 117-127
46. Uva, L., Janigro, D., de Curtis, M. (2006) Submillimolar and supramillimolar concentrations of pilocarpine induce, respectively, gamma oscillations and epileptiform activity in the in vitro isolated guinea pig brain. Soc for Neuroscience Annual Meeting Atlanta, GA.
47. Uva L., Librizzi L., Marchi N., Noe F., Bongiovanni R., Vezzani A., Janigro D., and de Curtis M. Acute induction of epileptiform discharges by pilocarpine in the in vitro isolated guinea-pig brain requires enhancement of blood-brain barrier permeability. Neuroscience 151 1 (2008) 303-312
48. van Vliet E.A., da Costa A.S., Redeker S., van Schaik R., Aronica E., and Gorter J.A. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 130 (2007) 521-534
49. Veldhuis W.B., Floris S., van der Meide P.H., Vos I.M., de Vries H.E., Dijkstra C.D., Bar P.R., and Nicolay K. Interferon-beta prevents cytokine-induced neutrophil infiltration and attenuates blood-brain barrier disruption. J. Cereb. Blood. Flow. Metab. 23 (2003) 1060-1069
50. Vezzani A., Conti M., De Luigi A., Ravizza T., Moneta D., Marchesi F., and De Simoni M.G. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J. Neurosci. 19 (1999) 5054-5065
51. Vezzani A., and Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46 (2005) 1724-1743
52. Vezzani A., and Janigro D. Inflammation. In: Engel G., and Pedley T.A. (Eds). Epilepsy: A Comprehensive Textbook (2008), Lippincott Williams and Wilkins., Philadelphia (Pa) 267-276
53. Vezzani A., Moneta D., Conti M., Richichi C., Ravizza T., De Luigi A., De Simoni M.G., Sperk G., Andell-Jonsson S., Lundkvist J., Iverfeldt K., and Bartfai T. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 11534-11539
54. Villani F., Bien C.G., and Avanzini G. Immunoglobulin and immunomodulatory therapy. In: Engel J., and Pedley T.A. (Eds). Epilepsy: A Comprehensive Textbook (2008), Lippincott Williams & Wilkins, Philadelphia, (Pa) 1519-1529
55. Wertheimer S.J., Myers C.L., Wallace R.W., and Parks T.P. Intercellular adhesion molecule-1 gene expression in human endothelial cells. Differential regulation by tumor necrosis factor-alpha and phorbol myristate acetate. J. Biol. Chem. 267 (1992) 12030-12035